位置:首页 > 蛋白库 > MYO10_RAT
MYO10_RAT
ID   MYO10_RAT               Reviewed;        2060 AA.
AC   D3ZJP6;
DT   21-MAR-2012, integrated into UniProtKB/Swiss-Prot.
DT   20-APR-2010, sequence version 1.
DT   03-AUG-2022, entry version 94.
DE   RecName: Full=Unconventional myosin-X;
DE   AltName: Full=Unconventional myosin-10;
GN   Name=Myo10;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-961; SER-964; SER-967 AND
RP   THR-1160, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (2.53 ANGSTROMS) OF 1178-1385, FUNCTION, SUBCELLULAR
RP   LOCATION, DOMAIN, AND INTERACTION WITH
RP   PHOSPHATIDYLINOSITOL-3,4,5-TRISPHOSPHATE.
RX   PubMed=21965296; DOI=10.1091/mbc.e11-04-0354;
RA   Lu Q., Yu J., Yan J., Wei Z., Zhang M.;
RT   "Structural basis of the myosin X PH1(N)-PH2-PH1(C) tandem as a specific
RT   and acute cellular PI(3,4,5)P(3) sensor.";
RL   Mol. Biol. Cell 22:4268-4278(2011).
CC   -!- FUNCTION: Myosins are actin-based motor molecules with ATPase activity.
CC       Unconventional myosins serve in intracellular movements. MYO10 binds to
CC       actin filaments and actin bundles and functions as a plus end-directed
CC       motor. Moves with higher velocity and takes larger steps on actin
CC       bundles than on single actin filaments (By similarity). The tail domain
CC       binds to membranous compartments containing phosphatidylinositol 3,4,5-
CC       trisphosphate or integrins, and mediates cargo transport along actin
CC       filaments. Regulates cell shape, cell spreading and cell adhesion.
CC       Stimulates the formation and elongation of filopodia. In hippocampal
CC       neurons it induces the formation of dendritic filopodia by trafficking
CC       the actin-remodeling protein VASP to the tips of filopodia, where it
CC       promotes actin elongation. Plays a role in formation of the podosome
CC       belt in osteoclasts (By similarity). {ECO:0000250|UniProtKB:Q9HD67,
CC       ECO:0000269|PubMed:21965296}.
CC   -!- SUBUNIT: Monomer, when in an inactive conformation in the cytosol.
CC       Homodimer in its active, membrane-bound conformation; antiparallel
CC       coiled coil-mediated dimer formation. Interacts with ECPAS. Interacts
CC       with DCC and ITGB5; the presence of DCC inhibits ITGB5 binding.
CC       Interacts with tubulin; ITGB5 or DCC binding inhibits tubulin binding.
CC       Interacts strongly with CALM3 and weakly with CALM, the CALM3
CC       interaction is essential for function in filopodial extension and
CC       motility. Interacts with ITGB1, ITGB3 and ITGB5. Interacts with NEO1.
CC       Interacts with VASP (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250}. Cell
CC       projection, lamellipodium {ECO:0000250}. Cell projection, ruffle
CC       {ECO:0000250}. Cytoplasm, cytoskeleton {ECO:0000250}. Cell projection,
CC       filopodium tip {ECO:0000250}. Cytoplasm, cell cortex {ECO:0000250}.
CC       Cell projection, filopodium membrane {ECO:0000250}; Peripheral membrane
CC       protein {ECO:0000250}. Cell membrane {ECO:0000269|PubMed:21965296};
CC       Peripheral membrane protein {ECO:0000269|PubMed:21965296}; Cytoplasmic
CC       side {ECO:0000269|PubMed:21965296}. Note=May be in an inactive,
CC       monomeric conformation in the cytosol. Detected in cytoplasmic punctae
CC       and in cell projections. Colocalizes with actin fibers. Interacts with
CC       microtubules. Undergoes forward and rearward movements within
CC       filopodia. Interaction with membranes containing phosphatidylinositol
CC       3,4,5-trisphosphate mediates localization at filopodium membranes (By
CC       similarity). {ECO:0000250}.
CC   -!- DOMAIN: Interaction between the motor domain and the tail leads to an
CC       inactive, monomeric conformation. Phospholipid binding via the PH
CC       domains leads to the formation of the active, dimeric form of the
CC       protein and strongly increases actin-dependent ATPase activity and
CC       motor activity (By similarity). {ECO:0000250}.
CC   -!- DOMAIN: Interacts with membranes containing phosphatidylinositol-3,4,5-
CC       trisphosphate via the PH domains. {ECO:0000269|PubMed:21965296}.
CC   -!- DOMAIN: IQ 3 domain mediates high-affinity calcium-dependent binding to
CC       CALM3/CLP. {ECO:0000250}.
CC   -!- DOMAIN: The SAH (single alpha-helix) region is characterized by a high
CC       content of charged residues which are predicted to stabilize the alpha-
CC       helical structure by ionic bonds (By similarity). It can refold after
CC       extension suggesting an in vivo force-dependent function (By
CC       similarity). An anti-parallel coiled coil is located C-terminal to the
CC       SAH domain and mediates dimerization (By similarity).
CC       {ECO:0000250|UniProtKB:F8VQB6, ECO:0000250|UniProtKB:P79114,
CC       ECO:0000250|UniProtKB:Q9HD67}.
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Myosin family. {ECO:0000305}.
CC   -!- CAUTION: Represents an unconventional myosin. This protein should not
CC       be confused with the conventional myosin-10 (MYH10). {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   RefSeq; XP_008758990.2; XM_008760768.2.
DR   PDB; 3TFM; X-ray; 2.53 A; A=1178-1385.
DR   PDBsum; 3TFM; -.
DR   AlphaFoldDB; D3ZJP6; -.
DR   SMR; D3ZJP6; -.
DR   STRING; 10116.ENSRNOP00000063102; -.
DR   iPTMnet; D3ZJP6; -.
DR   PaxDb; D3ZJP6; -.
DR   PeptideAtlas; D3ZJP6; -.
DR   Ensembl; ENSRNOT00000065897; ENSRNOP00000063102; ENSRNOG00000010161.
DR   GeneID; 310178; -.
DR   CTD; 4651; -.
DR   RGD; 1307193; Myo10.
DR   eggNOG; KOG4229; Eukaryota.
DR   GeneTree; ENSGT00940000155469; -.
DR   InParanoid; D3ZJP6; -.
DR   OMA; CEKGNIQ; -.
DR   OrthoDB; 16113at2759; -.
DR   TreeFam; TF316834; -.
DR   Reactome; R-RNO-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   PRO; PR:D3ZJP6; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000010161; Expressed in lung and 18 other tissues.
DR   ExpressionAtlas; D3ZJP6; baseline and differential.
DR   Genevisible; D3ZJP6; RN.
DR   GO; GO:0005938; C:cell cortex; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0030175; C:filopodium; ISO:RGD.
DR   GO; GO:0031527; C:filopodium membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0032433; C:filopodium tip; ISS:UniProtKB.
DR   GO; GO:0030027; C:lamellipodium; IEA:UniProtKB-SubCell.
DR   GO; GO:0016459; C:myosin complex; IEA:UniProtKB-KW.
DR   GO; GO:0043005; C:neuron projection; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; ISO:RGD.
DR   GO; GO:0005730; C:nucleolus; IEA:Ensembl.
DR   GO; GO:0001726; C:ruffle; IEA:UniProtKB-SubCell.
DR   GO; GO:0051015; F:actin filament binding; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0000146; F:microfilament motor activity; ISS:UniProtKB.
DR   GO; GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; ISS:UniProtKB.
DR   GO; GO:0060002; F:plus-end directed microfilament motor activity; ISS:UniProtKB.
DR   GO; GO:0030507; F:spectrin binding; ISO:RGD.
DR   GO; GO:0030705; P:cytoskeleton-dependent intracellular transport; ISS:UniProtKB.
DR   GO; GO:0022409; P:positive regulation of cell-cell adhesion; ISO:RGD.
DR   GO; GO:0008360; P:regulation of cell shape; ISS:UniProtKB.
DR   GO; GO:0051489; P:regulation of filopodium assembly; ISS:UniProtKB.
DR   CDD; cd14473; FERM_B-lobe; 1.
DR   CDD; cd13202; FERM_C_MyoX; 1.
DR   CDD; cd14873; MYSc_Myo10; 1.
DR   Gene3D; 1.20.80.10; -; 1.
DR   Gene3D; 1.25.40.530; -; 1.
DR   Gene3D; 2.30.29.30; -; 4.
DR   Gene3D; 3.40.850.10; -; 1.
DR   InterPro; IPR019749; Band_41_domain.
DR   InterPro; IPR014352; FERM/acyl-CoA-bd_prot_sf.
DR   InterPro; IPR035963; FERM_2.
DR   InterPro; IPR019748; FERM_central.
DR   InterPro; IPR000299; FERM_domain.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR031971; MYO10_CC.
DR   InterPro; IPR001609; Myosin_head_motor_dom.
DR   InterPro; IPR041797; MyoX_FERM_C.
DR   InterPro; IPR040640; MyoX_N_SH3.
DR   InterPro; IPR036124; MYSc_Myo10.
DR   InterPro; IPR000857; MyTH4_dom.
DR   InterPro; IPR038185; MyTH4_dom_sf.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   Pfam; PF00373; FERM_M; 1.
DR   Pfam; PF00612; IQ; 3.
DR   Pfam; PF16735; MYO10_CC; 1.
DR   Pfam; PF00063; Myosin_head; 1.
DR   Pfam; PF00784; MyTH4; 1.
DR   Pfam; PF00169; PH; 2.
DR   Pfam; PF18597; SH3_19; 1.
DR   PRINTS; PR00193; MYOSINHEAVY.
DR   SMART; SM00295; B41; 1.
DR   SMART; SM00015; IQ; 3.
DR   SMART; SM00242; MYSc; 1.
DR   SMART; SM00139; MyTH4; 1.
DR   SMART; SM00233; PH; 2.
DR   SUPFAM; SSF47031; SSF47031; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS50057; FERM_3; 1.
DR   PROSITE; PS50096; IQ; 3.
DR   PROSITE; PS51456; MYOSIN_MOTOR; 1.
DR   PROSITE; PS51016; MYTH4; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Actin-binding; ATP-binding; Calmodulin-binding;
KW   Cell membrane; Cell projection; Coiled coil; Cytoplasm; Cytoskeleton;
KW   Membrane; Motor protein; Myosin; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Repeat; Transport.
FT   CHAIN           1..2060
FT                   /note="Unconventional myosin-X"
FT                   /id="PRO_0000416245"
FT   DOMAIN          63..739
FT                   /note="Myosin motor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00782"
FT   DOMAIN          742..771
FT                   /note="IQ 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   DOMAIN          765..794
FT                   /note="IQ 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   DOMAIN          788..817
FT                   /note="IQ 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   DOMAIN          1214..1312
FT                   /note="PH 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          1394..1499
FT                   /note="PH 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          1549..1697
FT                   /note="MyTH4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00359"
FT   DOMAIN          1702..2046
FT                   /note="FERM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00084"
FT   REGION          619..641
FT                   /note="Actin-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00782"
FT   REGION          814..882
FT                   /note="SAH"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HD67"
FT   REGION          971..1039
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1064..1088
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          883..933
FT                   /evidence="ECO:0000250|UniProtKB:Q9HD67"
FT   COMPBIAS        1004..1033
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1064..1081
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         104
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HD67"
FT   BINDING         113
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HD67"
FT   BINDING         160..165
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HD67"
FT   BINDING         215
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HD67"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HD67"
FT   MOD_RES         961
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         964
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         967
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1160
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   STRAND          1180..1186
FT                   /evidence="ECO:0007829|PDB:3TFM"
FT   TURN            1189..1191
FT                   /evidence="ECO:0007829|PDB:3TFM"
FT   STRAND          1195..1202
FT                   /evidence="ECO:0007829|PDB:3TFM"
FT   STRAND          1205..1211
FT                   /evidence="ECO:0007829|PDB:3TFM"
FT   STRAND          1215..1223
FT                   /evidence="ECO:0007829|PDB:3TFM"
FT   HELIX           1225..1227
FT                   /evidence="ECO:0007829|PDB:3TFM"
FT   STRAND          1229..1231
FT                   /evidence="ECO:0007829|PDB:3TFM"
FT   HELIX           1233..1235
FT                   /evidence="ECO:0007829|PDB:3TFM"
FT   STRAND          1237..1243
FT                   /evidence="ECO:0007829|PDB:3TFM"
FT   STRAND          1245..1253
FT                   /evidence="ECO:0007829|PDB:3TFM"
FT   STRAND          1258..1264
FT                   /evidence="ECO:0007829|PDB:3TFM"
FT   HELIX           1265..1267
FT                   /evidence="ECO:0007829|PDB:3TFM"
FT   STRAND          1269..1273
FT                   /evidence="ECO:0007829|PDB:3TFM"
FT   TURN            1275..1277
FT                   /evidence="ECO:0007829|PDB:3TFM"
FT   STRAND          1278..1284
FT                   /evidence="ECO:0007829|PDB:3TFM"
FT   STRAND          1289..1293
FT                   /evidence="ECO:0007829|PDB:3TFM"
FT   HELIX           1297..1311
FT                   /evidence="ECO:0007829|PDB:3TFM"
FT   HELIX           1315..1318
FT                   /evidence="ECO:0007829|PDB:3TFM"
FT   TURN            1328..1330
FT                   /evidence="ECO:0007829|PDB:3TFM"
FT   STRAND          1332..1336
FT                   /evidence="ECO:0007829|PDB:3TFM"
FT   HELIX           1337..1339
FT                   /evidence="ECO:0007829|PDB:3TFM"
FT   STRAND          1340..1345
FT                   /evidence="ECO:0007829|PDB:3TFM"
FT   STRAND          1354..1359
FT                   /evidence="ECO:0007829|PDB:3TFM"
FT   STRAND          1362..1367
FT                   /evidence="ECO:0007829|PDB:3TFM"
FT   HELIX           1371..1381
FT                   /evidence="ECO:0007829|PDB:3TFM"
SQ   SEQUENCE   2060 AA;  237262 MW;  15CA25765D084CE6 CRC64;
     MDSFFPEGAR VWLRENGQHF PSTVNSCAEG VVVFQTDYGQ VFTYKQSTIT NQKVTAMHPL
     HEEGVDDMAS LTELHGGSIM YNLFQRYKRN QIYTYIGSII ASVNPYQPIA GLYERATMEQ
     YSRCHLGELP PHIFAIANEC YRCLWKRHDN QCVLISGESG AGKTESTKLI LKFLSVISQH
     SLDLCLQEKS SSVEQAILQS SPIMEAFGNA KTVYNNNSSR FGKFVQLNIC QKGNIQGGRI
     VDYLLEKNRV VRQNPGERNY HIFYALLAGL DQGEREEFYL SLPENYHYLN QSGCTEDKTI
     SDQESFRQVI EAMEVMQFSK EEVREVLRLL AGILHLGNIE FITAGGAQIS FKTALGRSAE
     LLGLDPTQLT DALTQRSMFL RGEEILTPLS VQQAVDSRDS LAMALYARCF EWVIKKINSR
     IKGKDDFKSI GILDIFGFEN FEVNHFEQFN INYANEKLQE YFNKHIFSLE QLEYSREGLV
     WEDIDWIDNG ECLDLIEKKL GLLALINEES HFPQATDSTL LEKLHNQHAN NHFYVKPRVA
     VNNFGVKHYA GEVQYDVRGI LEKNRDTFRD DLLNLLRESR FDFIYDLFEH ISSRNNQDTL
     KCGSKHRRPT VSSQFKDSLH SLMATLSSSN PFFVRCIKPN TQKMPDQFDQ AVVLNQLRYS
     GMLETVRIRK AGYAVRRPFQ DFYKRYKVLM RDLALPEDIR GKCTVLLQFY DASNSEWQLG
     KTKVFLRESL EQKLEKRREE EIDRAAMVIR AHILGYLARK QYRKVLCGVV TIQKNYRAFL
     ARKRFLHLKK AAIVFQKQLR GRLARKVYRQ LLAEKRELEE RKRLEEEKKR EEEERERKRA
     QREADLLRAQ QEAETRKQQE LEALQKNQRE ADLTRELEKQ RENKQVEEIL RLEKEIEDLQ
     RMKEQQELSL TEASLQKLQQ LRDEELRRLE DEACRAAQEF LESLNFDEID ECVRNIERSL
     SVGSEISGEL SELAENASGE KPNFNFSQPY PEEEVDEGFE ADDDAFKDSP NPSEHGHSDQ
     RTSGIRTSDD SSEEDPYMNY TVVPTSPSAD STVLLAASVQ DSASLHNSSS GESTYCMPQN
     NGDLPSPDGD YDYDQDDYED GAITSGSSVT FSNSYGSQWS PDYRYSVGTY NSSGAYRFSS
     EGAQSSFEDS EEDFDSRFDT DDELSYRRDS VYSCVTLPYF HSFLYMKGGL MNSWKRRWCV
     LKDETFLWFR SKQEALKQGW LHKKGGGSST LSRRNWKKRW FVLRQSKLMY FENDSEEKLK
     GTVEVRSAKE IIDNTNKENG IDIIMADRTF HLIAESPEDA SQWFSVLSQV HSSTDQEIRE
     MHDEQANPQN AVGTLDVGLI DSVCASDSPD RPNSFVIITA NRVLHCNADT PEEMHHWITL
     LQRSKGDTRV EGQEFIVRGW LHKEVKNSPK MSSLKLKKRW FVLTHNSLDY YKSSEKNALK
     LGTLVLNSLC SVVPPDEKIF KETGYWNVTV YGRKHCYRLY TKLLNEATRW SSAIQNVTDT
     KAPIDTPTQQ LIQDIKENCL NSDVVEQIYK RNPILRYTHH PLHSPLLPLP YGDINLNLLK
     DKGYTTLQDE AIKIFNSLQQ LESMSDPIPI IQGILQTGHD LRPLRDELYC QLIKQTNKVP
     HPGSVGNLYS WQILTCLSCT FLPSRGILKY LKFHLKRIRE QFPGTEMEKY ALFIYESLKK
     TKCREFVPSR DEIEALIHRQ EMTSTVYCHG GGSCKITINS HTTAGEVVEK LIRGLAMEDS
     RNMFALFEYN GQVDKAIESR TIVADVLAKF EKLAATSEAG DAPWKFYFKL YCFLDTDSMP
     KDSVEFAFMF EQAHEAVIHG HHPAPEESLQ VLAALRLQYL QGDYTLHTSV PPLEEVYSLQ
     RLKARISQST KTFTPYERLE KRRTSFLEGT LRRSFRTGTV ARQKVEEEQM LDMWIKEEIC
     SARASIIDKW KKLQGVSQEQ AMAKYMALIK EWPGYGSTLF DVECKEGGFP QELWLGVSAD
     AVSVYKRGEG KPLEVFQYEH ILSFGAPLAN TYKIVVDERE LLFETSEVVD VAKLMKAYIS
     MIVKKRYSTT RSLSSQGSSR
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024